THE OFFICE OF HEALTH ECONOMICS
Financial health, per its FY2024 accounts
The accounts state that the group realized a profit of £474,894 for the year ended 31 December 2024, driven by a surplus from its trading subsidiary which transferred profits via Gift Aid. Per the trustees' report, unrestricted reserves stood at £1,567,558, which is below the stated policy target of £1,856,000 (six months of payroll expenditure), though the group continues to work towards this target through budgeted surpluses.
What the accounts disclose
“In the band £350,001 - £360,000” — page 180
“The group's reserves target is 6 months of payroll expenditure. For 2025, that would be a target of £1,856,000. the group continue to work towards this by preparing a budget that delivers a 5% surplus to steadily increase the total reserves” — page 157
“Two Trustees (2023: Two) received fees for services during the period. Details of Trustees' fees, expenses and related party transactions are disclosed in Note 8 to the financial statements.” — page 158
“During the period the company received research grants totalling £150,000 (2023 - £200,000) from the ABPI. During the period, the group and company incurred support costs totalling £443,280 and £208,350 respectively (2023 - £368,280 and £106,285), which were recharged by the ABPI” — page 185
“During the period two Trustees received fees for services totalling £26,470 (2023 - £26,555) (refer to Note 8 for details). At the balance sheet date, no amount (2023 - £Nil) of this was outstanding.” — page 185
“During the period the company received research grants totalling £150,000 (2023 - £200,000) from the ABPI. During the period, the group and company incurred support costs totalling £443,280 and £208,350 respectively (2023 - £368,280 and £106,285), which were recharged by the ABPI” — page 185
“During the period two Trustees received fees for services totalling £26,470 (2023 - £26,555) (refer to Note 8 for details). At the balance sheet date, no amount (2023 - £Nil) of this was outstanding.” — page 185
“During the period the company received research grants totalling £150,000 (2023 - £200,000) from the ABPI. During the period, the group and company incurred support costs totalling £443,280 and £208,350 respectively (2023 - £368,280 and £106,285), which were recharged by the ABPI” — page 185
“During the period two Trustees received fees for services totalling £26,470 (2023 - £26,555) (refer to Note 8 for details). At the balance sheet date, no amount (2023 - £Nil) of this was outstanding.” — page 185
“The Office of Health Economics wholly owns OHE Consulting Limited, which carries out consulting work for third parties. Its profits fund our research and charity activities.” — page 5
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Anita Rose Charlesworth
- Richard David Torbett
- Rosanna Tarricone
- Thomas Allvin
- Victoria Jordan
- Wubbe Berend Frederik Brouwer
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £5.3m | £4.8m |
| 31/12/2023 | £4.5m | £4.6m |
| 31/12/2022 | £4.4m | £4.1m |
| 31/12/2021 | £4.1m | £3.6m |
| 31/12/2020 | £3.7m | £3.7m |
Common questions
Is THE OFFICE OF HEALTH ECONOMICS financially healthy?
The accounts state that the group realized a profit of £474,894 for the year ended 31 December 2024, driven by a surplus from its trading subsidiary which transferred profits via Gift Aid. Per the trustees' report, unrestricted reserves stood at £1,567,558, which is below the stated policy target of £1,856,000 (six months of payroll expenditure), though the group continues to work towards this target through budgeted surpluses. Its FY2024 accounts were audited by BDO LLP.
What does the highest-paid employee of THE OFFICE OF HEALTH ECONOMICS earn?
Per its FY2024 accounts, the highest-paid employee was in the £350,001 - £360,000 band.